Media Summary: Should drops be our first line of treatment - Hear from world-renown glaucoma expert and lead author of the LiGHT Predictable bone augmentation isn't just about the procedure—it's about the biology behind the results. Since the first GBR ...
Professor Gus Gazzard Publishes Ground Breaking Research - Detailed Analysis & Overview
Should drops be our first line of treatment - Hear from world-renown glaucoma expert and lead author of the LiGHT Predictable bone augmentation isn't just about the procedure—it's about the biology behind the results. Since the first GBR ...
